PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (Nasdaq:ARWR) announced today that European Patent No. 1093469, titled “Linear Cyclodextrin Copolymers,” has been issued to the California Institute of Technology. The patent is exclusively licensed to Arrowhead’s majority-owned subsidiary, Insert Therapeutics, a company commercializing delivery-enhanced therapeutics using a patented class of polymeric systems.
